Form 8-K - Current report:
SEC Accession No. 0001477932-25-001979
Filing Date
2025-03-26
Accepted
2025-03-25 17:59:55
Documents
18
Period of Report
2025-03-12
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K qron_8k.htm   iXBRL 8-K 28857
2 LETTER qron_ex161.htm EX-16.1 3326
8 qron_ex161img1.jpg GRAPHIC 3508
9 qron_ex161img2.jpg GRAPHIC 4163
  Complete submission text file 0001477932-25-001979.txt   158995

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qron-20250312.xsd EX-101.SCH 5874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qron-20250312_lab.xml EX-101.LAB 13171
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qron-20250312_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qron-20250312_pre.xml EX-101.PRE 8249
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qron-20250312_def.xml EX-101.DEF 2099
20 EXTRACTED XBRL INSTANCE DOCUMENT qron_8k_htm.xml XML 3533
Mailing Address 28-10 JACKSON AVENUE, #26N LONG ISLAND CITY NY 11101
Business Address 28-10 JACKSON AVENUE, #26N LONG ISLAND CITY NY 11101 212-945-2080
Qrons Inc. (Filer) CIK: 0001689084 (see all company filings)

EIN.: 813623646 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55800 | Film No.: 25769552
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)